Manipal Health share price made its stock market debut on Wednesday, August 5, 2026, listing at ₹652 per share on the NSE, a premium of 10.51% over its IPO issue price of ₹590. On the BSE, the stock listed at ₹655 per share, reflecting a premium of 11.02% over the issue price.
The listing follows the company's ₹9,275-crore IPO, which was open for subscription from July 29 to July 31, 2026.
As of August 5, 2026, at 10:02 AM, Manipal Health share price was trading at ₹652.15 on the NSE, up 10.53% from its IPO issue price of ₹590.
The stock opened at ₹652, touched an intraday high of ₹662, and a low of ₹652 during early trade. The total market capitalisation of the company stood at ₹85,821.79 crore.
The IPO received an overall subscription of 4.92 times.
Qualified Institutional Buyers (QIBs): 8.25 times
Non-Institutional Investors (NIIs): 1.02 times
Retail Investors: 0.93 times
Ahead of the public issue, the company raised ₹4,167 crore from 133 anchor investors at ₹590 per share.
The IPO comprised a fresh issue of ₹8,000 crore and an offer for sale (OFS) of 2.16 crore shares by existing shareholders. Following the issue, the promoters' shareholding is expected to decline from 69.87% to 61.84%.
Read More: Dhoot Transmission IPO Price Band Fixed at ₹829–₹871 Per Share: Check Key Dates and Issue Details
The company plans to use the IPO proceeds primarily to reduce debt and strengthen its balance sheet.
₹5,552.7 crore will be used to repay borrowings, mainly those incurred for the acquisition of Sahyadri Hospitals.
₹574 crore will be used to acquire the remaining 9.84% stake in Sahyadri Hospitals.
As of March 2026, Manipal Health had total borrowings of ₹11,185 crore. The proposed repayment is expected to reduce its debt by nearly 47.5%.
Manipal Health is India's largest private hospital chain by licensed bed capacity, operating 49 hospitals with 13,037 licensed beds across 14 states and Union Territories as of March 31, 2026.
For FY26, the company reported:
Total income rose 26% year-on-year to ₹10,520.5 crore.
EBITDA increased to ₹2,795.9 crore from ₹2,247.1 crore in FY25.
Net profit declined to ₹916.5 crore from ₹1,081.7 crore a year earlier.
Manipal Health entered the stock market with a listing premium of more than 10% over its IPO price. The company plans to use a significant portion of the IPO proceeds to reduce debt and increase its stake in Sahyadri Hospitals, while its FY26 financials showed higher revenue and EBITDA despite a decline in net profit.
Read stock market news in Hindi. Head to Angel One's share market news in Hindi for comprehensive coverage.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Aug 5, 2026, 10:04 AM IST
Rakesh Deshmukh
Rakesh Deshmukh is a financial content specialist with around 3 years of experience writing impactful content across equities, mutual funds, IPOs, and personal finance. At Angel One, he decodes real-time market trends and breaking news, helping investors and traders stay updated. He also helps investors make informed decisions by simplifying market fundamentals and technical analysis. He holds a bachelor’s degree in commerce.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
